Beijing Strong Biotechnologies,Inc. (SHE:300406)
China flag China · Delayed Price · Currency is CNY
12.69
+0.23 (1.85%)
Nov 2, 2026, 3:04 PM CST

SHE:300406 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Net Income
250.64189.87538.29523.74389.1405.65
Depreciation & Amortization
68.669.427156.2154.8243.62
Other Amortization
3.512.681.170.960.881.87
Loss (Gain) From Sale of Assets
2.872.872.113.52.68-0.16
Asset Writedown & Restructuring Costs
175.6175.61.380.215.320.11
Loss (Gain) From Sale of Investments
-12.14-12.14-9.61-20.76-19.08-11.53
Provision & Write-off of Bad Debts
26.3526.353.3923.4439.1537.13
Other Operating Activities
-4.3156.7148.0452.1760.2383.8
Change in Accounts Receivable
100.07100.0715.81-69.02-84.94-184.23
Change in Inventory
20.920.9-16.2-13.21-11.24-31.01
Change in Accounts Payable
-57.58-57.58-31.8837.36-33.218.5
Operating Cash Flow
564.85565.11614.01585.09396.17341.1
Operating Cash Flow Growth
-11.41%-7.96%4.94%47.69%16.14%177.18%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Capital Expenditures
-21.5-39.24-67.65-148.03-96.48-65.2
Sale of Property, Plant & Equipment
-0.030.060.211.03-0.23
Cash Acquisitions
-----1.44-
Investment in Securities
-9.14-386.71-73.2815-341.28-1,256
Other Investing Activities
-57.27-49.43122.14.79-1.638.9
Investing Cash Flow
-87.94-475.32-18.62-127.21-440.82-1,312

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Long-Term Debt Issued
-1.3223.2106.591,2901,122
Long-Term Debt Repaid
--129.35-33.48-104.44-1,154-302.34
Lease Payments
-1.94-1.94-1.77-2.63-1.89-1.19
Net Debt Issued (Repaid)
-1.84-128.04-10.282.15136.16819.94
Issuance of Common Stock
--3.2137.09-37.33
Repurchase of Common Stock
-18.79-18.79-44.66-49.45-51.1-
Common Dividends Paid
-626.83-537.14-124.19-64.66-90.65-78.61
Other Financing Activities
15.73.15-0.550.12-4.99-1.98
Financing Cash Flow
-631.76-680.81-176.48-74.76-10.58776.67

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Foreign Exchange Rate Adjustments
-1.21-0.390.520.21.03-0.36
Net Cash Flow
-156.06-591.41419.43383.32-54.21-194.67

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Free Cash Flow
543.35525.87546.36437.06299.69275.9
Free Cash Flow Growth
-9.26%-3.75%25.01%45.84%8.63%160.74%
Free Cash Flow Margin
39.55%38.80%32.93%25.09%19.84%17.25%
Free Cash Flow Per Share
0.930.890.910.730.490.47
Levered Free Cash Flow
452309.84338293.07157.06211.82
Unlevered Free Cash Flow
460.28340.74367.75322.44189.96225.32
Free Cash Flow After Leases
541.42523.93544.6434.43297.8274.71

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Cash Income Tax Paid
209.04197.68197.19189.57162.92165.81
Change in Working Capital
53.7253.72-41.76-54.37-136.93-219.38